Severe Late-Onset Acute Cellular Rejection in a Pediatric Patient With Isolated Small Intestinal Transplant Rescued With Aggressive Immunosuppressive Approach: A Case Report

2019 ◽  
Vol 51 (9) ◽  
pp. 3181-3185 ◽  
Author(s):  
Amrita Narang ◽  
Dong Xi ◽  
Tania Mitsinikos ◽  
Yuri Genyk ◽  
Dan Thomas ◽  
...  
Keyword(s):  
Case Report ◽  
Pediatric Patient ◽  
Late Onset ◽  
Acute Cellular Rejection ◽  
Small Intestinal ◽  
Intestinal Transplant ◽  
Cellular Rejection

LATE-ONSET SEVERE ACUTE CELLULAR REJECTION AFTER ADULT ABO-INCOMPATIBLE LIVER TRANSPLANTATION: A CASE REPORT

2004 ◽  
Vol 77 (12) ◽  
pp. 1909-1910 ◽  
Author(s):  
Daisuke Morioka ◽  
Hitoshi Sekido ◽  
Ken-ichi Matsuo ◽  
Kazuhisa Takeda ◽  
Shuji Saito ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Case Report ◽  
Late Onset ◽  
Acute Cellular Rejection ◽  
Cellular Rejection

scholarly journals Mycophenolate mofetil toxicity mimicking acute cellular rejection in a small intestinal transplant

2017 ◽  
Vol 7 (1) ◽  
pp. 98 ◽  
Author(s):  
Ross Apostolov ◽  
Khashayar Asadi ◽  
Julie Lokan ◽  
Ning Kam ◽  
Adam Testro
Keyword(s):  
Mycophenolate Mofetil ◽  
Acute Cellular Rejection ◽  
Small Intestinal ◽  
Intestinal Transplant ◽  
Cellular Rejection

scholarly journals Acute Liver Rejection in a Multiple Myeloma Patient Treated with Lenalidomide

2020 ◽  
Vol 2020 ◽  
pp. 1-4
Author(s):  
Iuliana Vaxman ◽  
John Eaton ◽  
Hee Eun Lee ◽  
Morie A. Gertz
Keyword(s):  
Multiple Myeloma ◽  
Mycophenolate Mofetil ◽  
Case Report ◽  
Allograft Rejection ◽  
Acute Cellular Rejection ◽  
Primary Biliary Cholangitis ◽  
Myeloma Patient ◽  
Multiple Myeloma Patient ◽  
First Case ◽  
Cellular Rejection

Herein we present a patient that underwent a liver transplant due to primary biliary cholangitis (PBC) and after 9 years developed multiple myeloma. Following the cessation of mycophenolate mofetil and 2 weeks after lenalidomide treatment was started, the patient experienced acute cellular rejection. The patient recovered after treatment with corticosteroids, resumption of mycophenolate mofetil, and cessation of lenalidomide. Lenalidomide-associated allograft rejection has been reported in other organs. However, this is the first case report of liver rejection induced by lenalidomide.

Sign in / Sign up

Export Citation Format

Share Document